Guangzhou Trauer Biotechnology Co., Ltd.
标题
标题
Home
>
News
>
Major Breakthrough by Trauer Biotech: First-Generation Recombinant Type III Human Collagen Preparation Technology Leads a New Era in Medical Aesthetics
Major Breakthrough by Trauer Biotech: First-Generation Recombinant Type III Human Collagen Preparation Technology Leads a New Era in Medical Aesthetics
Prev:
Trauer Biotech Welcomes Thai FDA and FTI Delegation for Exchange on Atelocollagen Innovation and Biomedical Applications
Next:
Trauer Biotech Shines at CPHI Frankfurt 2025: High-Purity Bioactive Collagen Ingredients Garner Global Attention, Accelerating International Expansion
